Manu Sondhi

TL;DR: In this article, the relative safety and efficacy of radiofrequency catheter ablation (RFA) for atrial fibrillation were evaluated using a randomized clinical trial, and the results showed that RFA is safe and effective.

TL;DR: In conclusion, studies of RFA for the treatment of patients with AFL and SVT report high efficacy rates and low rates of complications.

TL;DR: It cannot exclude the possibility that an increased use of background therapy with angiotensin-converting enzyme inhibitors, β-blockers, lipid-lowering agents, and systemic anticoagulation over time may have contributed to the apparent decline in atrial fibrillation.

TL;DR: Tazemetostat (TAZ), an enhancer of zeste homolog 2 (EZH2) inhibitor, is approved by the US Food and Drug Administration for the treatment of patients with relapsed/refractory (R/R) follicular lymphoma (FL) who have received ≥2 prior therapies or who have no satisfactory alternative treatment options as discussed by the authors .